Cloud Based Drug Discovery Platforms Market 2030 Market Unlock the Future: 2030 Market Report and Forecast

The Global Cloud-Based Drug Discovery Platforms Market size is expected to grow from USD 2.22 Billion in 2022 to USD 5.04 Billion by 2030, at a CAGR of 10.8% during the forecast period (2023-2030).

Through internet-connected devices like PCs, smartphones, tablets, and wearables, cloud computing technology provides users with access to storage, data, applications, and servers. Solution providers for cloud computing keep and handle data in a location apart from users. Additionally, using cloud computing gives you the option to store and retrieve programs and data online rather than on a hard drive. Cloud-based drug discovery systems enable global collaboration between scientists and businesses, which is beneficial for pharmaceutical and biotechnology enterprises.  Moreover, by leveraging the high-performance computing power and AI/ML capabilities on the vast cloud infrastructure at a reasonable cost, cloud-based drug discovery platforms lower risk and expedite the drug development process.

Players Covered in Cloud Based Drug Discovery Platforms Market are:

Accenture PLC (Ireland), Acelot Inc (US), Cloud Pharmaceuticals Inc. (US), Dassault Systemes (France), IBM Corporation (US), SAS Institute Inc. (the US), Tata Consultancy Services Ltd. (India), WuXi AppTec (China), Collaborative Drug Discovery (CDD), SCYNEXIS Inc. (the US), Medidata (US), Certara (US), Google (US), Cloudpharm, Amazon Web Services Inc. (US) and other major players.

Your Free Sample Report: Ready for Download!

https://introspectivemarketresearch.com/request/14764

Introspective Market Research delivers comprehensive market research studies, providing valuable insights and strategic guidance to global businesses. We ensure reliable reports for informed decision-making.

With In-Depth examination of several affecting internal and external factors such as supply and sales channels, including upstream and downstream fundamentals, this report presents a complete analysis on the Cloud Based Drug Discovery Platforms market ecosystem. To ensure the utmost accuracy and reliability, we draw upon numerous primary and secondary sources. Employing industry-standard tools such as Porter's Five Forces Analysis, SWOT Analysis, and Price Trend Analysis, our research provides a comprehensive evaluation of the market segments and market landscape. This research study goes beyond conventional boundaries with extensive geographical coverage, allowing for a comprehensive understanding of regional trends.

Segmentation Analysis of Cloud Based Drug Discovery Platforms Market:

By Type

• Infrastructure As A Service {IaaS}
• Software As A Service {SaaS}
• Platform As A Service {PaaS}

By Deployment Mode

• Public
• Private
• Hybrid

By End User

• Pharmaceutical Vendors
• Biotech Vendors
• Contract Research Organizations
• Others

Tailor-Made Reports - Your Insights, Your Way!

https://introspectivemarketresearch.com/custom-research/14764

Regional Analysis of Cloud Based Drug Discovery Platforms Market:

Over the course of the forecast period, cloud-based drug discovery platforms are anticipated to be most prevalent in the North American area. The primary driver behind the growth of cloud-based drug discovery platforms in this region is the increasing number of pharmaceutical companies and the requirement to manage the massive amount of data created by this industry. Moreover, there are several well-known cloud computing service providers in nations like the US and Canada. Cloud-based drug discovery platforms are being used by pharmaceutical and biotechnology suppliers due to the increasing prevalence of diseases and the need to find effective medications more quickly.

By Region

• North America (US, Canada, Mexico)
• Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
• Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
• Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
• Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
• South America (Brazil, Argentina, Rest of SA)

Key Industry Developments In Cloud Based Drug Discovery Platforms Market

• In October 2021, Medidata declared the launch of its product Medidata sensor cloud network at NEXT Global 2021. With this Medidata sensor cloud network, contract research organizations (CROs), analytics companies, device manufacturers, drug and vaccine developers, and academia will be able to collaborate and solve challenges associated with sensor integrations, standardization of sensor data, and the development of digital biomarkers and algorithms.
• In October 2021, Certara, Inc. a global leader in biosimulation, declared the acquisition of Pinnacle 21, a prominent service provider of SaaS solutions for clinical data fitness, regulatory compliance, and submission readiness. This acquisition is expected to boost Certara's ability to address vital decisions that further de-risk and accelerate the drug development process.
• In March 2021, Cleveland Clinic and IBM have entered a strategic 10-year collaboration to establish the Discovery Accelerator, a joint Cleveland Clinic - IBM center. This joint venture is formed to enhance the pace of drug discovery in healthcare and life sciences through the usage of high-performance computing on the hybrid cloud, artificial intelligence (AI), and quantum computing technologies.

Make Your Move - Secure Your Purchase!

https://introspectivemarketresearch.com/checkout/?user=1&_sid=14764

About us:

Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1 773 382 1049

Email: sales@introspectivemarketresearch.com

LinkedIn | Twitter | Facebook